An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia

CONCLUSION: A conservative estimate is that 1% of cancer patients in Australia (or 2% of patients recommended for radiation therapy) may preferentially benefit from CIRT for initial therapy of radiation resistant tumours, or to boost persistently active disease after other therapies, or for re-irradiation of recurrent disease. On this basis, one national carbon ion facility with up to four treatment rooms is justified for Australian patients.PMID:37480996 | DOI:10.1016/j.radonc.2023.109816

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - July 22, 2023 Category: Radiology Authors: Verity Ahern Sebastian Adeberg Piero Fossati Richard Garrett Bradford Hoppe Anita Mahajan Ester Orlandi Roberto Orecchia Dale Prokopovich Jan Seuntjens David Thwaites Daniel Trifiletti Richard Tsang Hiroshi Tsuji Source Type: research